+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification



Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification



Journal of Medicinal Chemistry 47(8): 1956-1961



The plethora of actions of 1alpha,25(OH)(2)D(3) in various systems suggested wide clinical applications of vitamin D nuclear receptor (VDR) ligands in treatments of inflammation, dermatological indication, osteoporosis, cancers, and autoimmune diseases. More than 3000 vitamin D analogues have been synthesized in order to reduce the calcemic side effects while maintaining the transactivation potency of these ligands. Here, we report the crystal structures of VDR ligand binding domain bound to two vitamin D agonists of therapeutical interest, calcipotriol and seocalcitol, which are characterized by their side chain modifications. These structures show the conservation of the VDR structure and the adaptation of the side chain anchored by hydroxyl moieties. The structure of VDR-calcipotriol helps us to understand the structural basis for for the switching of calcipotriol to a receptor antagonist by further side chain modification. The VDR-seocalcitol structure, in comparison with the structure of VDR-KH1060, a superagonist ligand closely related to seocalcitol, shows adaptation of the D ring and position of C-21 in order to adapt its more rigid side chain.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011912716

Download citation: RISBibTeXText

PMID: 15055995

DOI: 10.1021/jm0310582


Related references

Synthesis of new vitamin K analogues as steroid and xenobiotic receptor (SXR) agonists: insights into the biological role of the side chain part of vitamin K. Journal of Medicinal Chemistry 54(13): 4918-4922, 2011

Potent antagonist for the vitamin D receptor: vitamin D analogues with simple side chain structure. Journal of Medicinal Chemistry 53(15): 5813-5826, 2010

The Seleno-Acetal Route to Side-Chain-Modified 1α-Hydroxy-Vitamin D Analogues: Stereoselective Synthesis of the New 22Z Isomer of MC 903 (Calcipotriol). Synlett 1990(03): 157-159, 1990

Combination of triple bond and adamantane ring on the vitamin D side chain produced partial agonists for vitamin D receptor. Journal of Medicinal Chemistry 57(10): 4073-4087, 2014

Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism. Journal of Medicinal Chemistry 51(17): 5320-5329, 2008

Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol. Archives of Biochemistry and Biophysics 460(2): 172-176, 2007

1-alpha,24S-dihydroxy-26,27-cyclo-22-YNE-vitamin D-3: The side chain triple bond analogue of MC 903 (calcipotriol). Bioorganic and Medicinal Chemistry Letters 3(9): 1841-1844, 1993

Side chain structural requirements of 1 alpha hydroxylated vitamin d 3 analogs for optimal binding to chick intestinal vitamin d receptor. Federation Proceedings 39(3): ABSTRACT 1555, 1980

Identification of a 5-HT4 receptor antagonist clinical candidate through side-chain modification. Bioorganic and Medicinal Chemistry Letters 15(6): 1697-1700, 2005

The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity. Organic Letters 5(22): 4033-4036, 2003

Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor. Molecular Cancer Therapeutics 7(10): 3187-3194, 2008

Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation. Journal of Steroid Biochemistry and Molecular Biology 103(3-5): 235-242, 2007

Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor. Molecular Pharmacology 63(6): 1230-1237, 2003

The seleno acetal route to side chain modified 1 alpha hydroxyvitamin d analogues stereoselective synthesis of the new 22z isomer of mc 903 calcipotriol. Synlett (3): 157-159, 1990

Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients. Archives of Dermatological Research 294(1-2): 1-5, 2002